Impact of radiation and hepatitis virus infection on risk of hepatocellular carcinoma

In cohort studies of atomic bomb survivors and Mayak nuclear facility workers, radiation‐associated increases in liver cancer risk were observed, but hepatitis B virus (HBV) and hepatitis C virus (HCV) infections were not taken strictly into account. We identified 359 hepatocellular carcinoma (HCC) cases between 1970 and 2002 in the cohort of atomic bomb survivors and estimated cumulative incidence of HCC by radiation dose. To investigate contributions of radiation exposure and hepatitis virus infection to HCC risk, we conducted a nested case‐control study using sera stored before HCC diagnosis in the longitudinal cohort of atomic bomb survivors. The study included 224 HCC cases and 644 controls that were matched to the cases on gender, age, city, and time and method of serum storage, and countermatched on radiation dose. The cumulative incidence of HCC by follow‐up time and age increased significantly with radiation dose. The relative risk (RR) of HCC for radiation at 1 Gy was 1.67 (95% confidence interval: 1.22‐2.35) with adjustment for alcohol consumption, body mass index (BMI), and smoking habit, whereas the RRs for HBV or HCV infection alone were 63 (20‐241) and 83 (36‐231) with such adjustment, respectively. Those estimates changed little when radiation and hepatitis virus infection were fit simultaneously. The RR of non‐B, non‐C HCC at 1 Gy was 1.90 (1.02‐3.92) without adjustment for alcohol consumption, BMI, or smoking habit and 2.74 (1.26‐7.04) with such adjustment. Conclusion: These results indicate that radiation exposure and HBV and HCV infection are associated independently with increased HCC risk. In particular, radiation exposure was a significant risk factor for non‐B, non‐C HCC with no apparent confounding by alcohol consumption, BMI, or smoking habit. (HEPATOLOGY 2011;53:‐)

[1]  D. Seidel,et al.  Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidence , 2010, Alimentary pharmacology & therapeutics.

[2]  I. B. Tanaka,et al.  Adiposity in Female B6C3F1 Mice Continuously Irradiated with Low-Dose-Rate γ Rays , 2010, Radiation research.

[3]  T. Umemura,et al.  Epidemiology of hepatocellular carcinoma in Japan , 2009, Journal of Gastroenterology.

[4]  Y. Aizawa,et al.  Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo , 2008, Journal of Gastroenterology.

[5]  Dale L Preston,et al.  Lung, liver and bone cancer mortality in Mayak workers , 2008, International journal of cancer.

[6]  K. Chayama,et al.  Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[7]  D. L. Preston,et al.  Solid Cancer Incidence in Atomic Bomb Survivors: 1958–1998 , 2007, Radiation research.

[8]  Tsuneya Matsumoto,et al.  Cause of Death and Neoplasia in Mice Continuously Exposed to Very Low Dose Rates of Gamma Rays , 2007, Radiation research.

[9]  K. Chayama,et al.  Feasibility of Freeze-Dried Sera for Serological and Molecular Biological Detection of Hepatitis B and C Viruses , 2006, Journal of Clinical Microbiology.

[10]  V. Khokhryakov,et al.  INFLUENCE OF ALPHA AND GAMMA RADIATIONS AND NON-RADIATION RISK FACTORS ON THE INCIDENCE OF MALIGNANT LIVER TUMORS AMONG MAYAK PA WORKERS , 2006, Health physics.

[11]  Mitsuhiko Noda,et al.  Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. , 2006, Archives of internal medicine.

[12]  N. Yoshiike,et al.  Epidemiological aspects of obesity and NASH/NAFLD in Japan. , 2005, Hepatology research : the official journal of the Japan Society of Hepatology.

[13]  T. Mizuno,et al.  Relationship of hepatocellular carcinoma to soya food consumption: A cohort‐based, case‐control study in Japan , 2005, International journal of cancer.

[14]  J. Marrero,et al.  Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. , 2005, Journal of hepatology.

[15]  S. Caldwell,et al.  Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.

[16]  Jian-Min Yuan,et al.  Environmental factors and risk for hepatocellular carcinoma. , 2004, Gastroenterology.

[17]  D. Lobo,et al.  Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma. , 2004, Journal of hepatology.

[18]  C. Land,et al.  Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure. , 2004, International journal of epidemiology.

[19]  H. El‐Serag,et al.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.

[20]  A. Hida,et al.  Effects of radiation on fatty liver and metabolic coronary risk factors among atomic bomb survivors in Nagasaki. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[21]  Charles Mw,et al.  Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. , 2003 .

[22]  Bryan Langholz,et al.  Selecting Controls for Assessing Interaction in Nested Case-control Studies , 2003, Journal of epidemiology.

[23]  K. Kodama,et al.  Prevalence of Hepatitis B Virus Infection among Atomic Bomb Survivors , 2003, Radiation research.

[24]  T. Mizuno,et al.  Hepatocellular carcinoma among atomic bomb survivors: Significant interaction of radiation with hepatitis C virus infections , 2003, International journal of cancer.

[25]  J. Marrero,et al.  NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States , 2002, Hepatology.

[26]  G. Sharp.  The relationship between internally deposited alpha-particle radiation and subsite-specific liver cancer and liver cirrhosis: an analysis of published data. , 2002, Journal of radiation research.

[27]  A. Peiris,et al.  Insulin: a novel factor in carcinogenesis. , 2002, The American journal of the medical sciences.

[28]  T. Mizuno,et al.  Liver cancer in atomic-bomb survivors: histological characteristics and relationships to radiation and hepatitis B and C viruses. , 2001, Journal of radiation research.

[29]  N A Koshurnikova,et al.  Liver Cancers in Mayak Workers , 2000, Radiation research.

[30]  K. Kodama,et al.  Prevalence of Anti-hepatitis C Virus Antibody and Chronic Liver Disease among Atomic Bomb Survivors , 2000, Radiation research.

[31]  G. Beebe,et al.  Effects of radiation on incidence of primary liver cancer among atomic bomb survivors. , 1999, Radiation research.

[32]  T. Seyama,et al.  Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivors. , 1998, Journal of the National Cancer Institute.

[33]  M. Andersson.  Long-term effects of internally deposited alpha-particle emitting radionuclides. Epidemiological, pathological and molecular-biological studies of Danish Thorotrast-administered patients and their offspring. , 1997, Danish medical bulletin.

[34]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[35]  S. Akiba,et al.  Prevalence of hepatitis B surface antigen, hepatitis B e antigen and antibody, and antigen subtypes in atomic bomb survivors. , 1995, Radiation research.

[36]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[37]  J B Cologne,et al.  OPTIMAL CASE‐CONTROL MATCHING IN PRACTICE , 1995, Epidemiology.

[38]  Bryan Langholz,et al.  Counter-matching: A stratified nested case-control sampling method , 1995 .

[39]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. , 1994, Radiation research.

[40]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality. , 1994, Radiation research.

[41]  D. Preston,et al.  Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies. , 1994, Radiation research.

[42]  H. Kato,et al.  The relationship of hepatitis B surface antigen and antibody to atomic bomb radiation in the Adult Health Study sample, 1975-1977. , 1983, American journal of epidemiology.

[43]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[44]  P. Baxter,et al.  Angiosarcoma of the liver: a marker tumour for the late effects of Thorotrast in Great Britain. , 1980, British Journal of Cancer.

[45]  R. King,et al.  Hepatitis-associated antigen in atomic bomb survivors and nonexposed control subjects: seroepidemiologic survey in a fixed cohort. , 1973, The Journal of infectious diseases.

[46]  George D. Kerr,et al.  Reassessment of the atomic bomb radiation dosimetry for Hiroshima and Nagasaki : dosimetry system 2002 : report of the joint US-Japan working group , 2005 .